ArticleFrontiers in nutrition2026
Dietary zinc intake, serum zinc concentrations, and disease activity in children with juvenile idiopathic arthritis: a case-control study.
Article in Frontiers in nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Zinc is an essential trace element involved in immune regulation and inflammatory responses. Children with juvenile idiopathic arthritis (JIA) may be at increased risk of nutritional deficiencies due to chronic inflammation, altered dietary intake, and long-term treatment. However, evidence regarding dietary zinc intake and serum zinc status in JIA remains inconsistent. This study aimed to evaluate dietary zinc intake and serum zinc concentrations in children with JIA and healthy controls and to explore their potential relationship with disease activity. Methods: This unmatched case-control study included children with JIA and healthy controls aged 6-18 years. Dietary zinc intake was assessed using a semi-quantitative food frequency questionnaire. Serum zinc concentrations were measured using a colorimetric assay. Demographic, clinical, laboratory, dietary, and treatment characteristics were analyzed according to serum zinc status within the JIA cohort. Results: Children with JIA had significantly lower dietary zinc intake than healthy controls (median 5.85 vs. 7.59 mg/day, Conclusions: Children with JIA had substantially lower dietary zinc intake than healthy controls, whereas mean serum zinc concentrations did not differ significantly between the groups. Low serum zinc concentration was associated with selected measures of disease activity but did not show an independent or causal relationship with systemic inflammation. Prospective studies are needed to clarify the temporal relationships between dietary zinc intake, serum zinc status, inflammation, and disease activity and to determine whether nutritional interventions have clinically relevant effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.